Clozapine use in schizophrenia: findings of the Research on Asia Psychotropic Prescription (REAP) studies from 2001 to 2009

References

• Idanpaan-Heikkila J, Alhava E, Olkinuora M, Palva I. Clozapine and agranulocytosis [letter]. Lancet 1975; 2:611.
   PubMed Web of Science ®Google Scholar
• Kane J, Honigfeld G, Singer J, Meltzer H. Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine. Arch Gen Psychiatry 1988; 45:789–796.
   PubMed Web of Science ®Google Scholar
• Drew LR. Controls on clozapine must be reviewed. Aust N Z J Psychiatry 2010; 44:490.
   PubMed Web of Science ®Google Scholar
• Iqbal MM, Rahman A, Husain Z, Mahmud SZ, Ryan WG, Feldman JM. Clozapine: a clinical review of adverse effects and management. Ann Clin Psychiatry 2003; 15:33–48.
   PubMedGoogle Scholar
• Meltzer HY, Alphs L, Green AI . Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT). Arch Gen Psychiatry 2003; 60:82–91.
   PubMed Web of Science ®Google Scholar
• Puri BK, Taylor DG, Alcock ME. Low-dose maintenance clozapine treatment in the prophylaxis of bipolar affective disorder. Br J Clin Pract 1995; 49:333–334.
   PubMedGoogle Scholar
• Zarate CA Jr, Tohen M, Baldessarini RJ. Clozapine in severe mood disorders. J Clin Psychiatry 1995; 56:411–417.
   PubMed Web of Science ®Google Scholar
• Benedetti F, Sforzini L, Colombo C, Maffei C, Smeraldi E. Low-dose clozapine in acute and continuation treatment of severe borderline personality disorder. J Clin Psychiatry 1998; 59:103–107.
   PubMed Web of Science ®Google Scholar
• O'Brien A. Starting clozapine in the community: a UK perspective. CNS Drugs 2004; 18:845–852.
   PubMed Web of Science ®Google Scholar
• Young CR, Bowers MB Jr, Mazure CM. Management of the adverse effects of clozapine. Schizophr Bull 1998; 24:381–390.
   PubMed Web of Science ®Google Scholar
• Si TM, Shu L, Yu X . Antipsychotic drug patterns of schizophrenia in China: a cross-sectional study [in Chinese]. Chin J Psychiatry 2004; 37:152–155.
   Google Scholar
• Liu TL, Li CY. The comparison of use of antipsychotics in first-episode patients with schizophrenia [in Chinese]. Med J Chin People Health 2003; 15:289–290.
   Google Scholar
• Xiang YT, Weng YZ, Leung CM, Tang WK, Ungvari GS. Clinical correlates of clozapine prescription for schizophrenia in China. Hum Psychopharmacol 2007; 22:17–25.
   PubMed Web of Science ®Google Scholar
• Haro JM, Salvador-Carulla L. The SOHO (Schizophrenia Outpatient Health Outcome) study: implications for the treatment of schizophrenia. CNS Drugs 2006; 20:293–301.
   PubMed Web of Science ®Google Scholar
• APA. Practice guideline for the treatment of patients with schizophrenia. Washington, DC: American Psychiatric Press, 1997.
   Google Scholar
• Kane JM, Aguglia E, Altamura AC . Guidelines for depot antipsychotic treatment in schizophrenia. European Neuropsychopharmacolology Consensus Conference in Siena, Italy. Eur Neuropsychopharmacol 1998; 8:55–66.
   PubMed Web of Science ®Google Scholar
• Woods SW. Chlorpromazine equivalent doses for the newer atypical antipsychotics. J Clin Psychiatry 2003; 64:663–667.
   PubMed Web of Science ®Google Scholar
• Chinese Medical Association. Guideline for the prevention and treatment of schizophrenia in China. Beijing: Chinese Medical Association, 2003.
   Google Scholar
• Wahlbeck K, Cheine M, Essali A, Adams C. Evidence of clozapine's effectiveness in schizophrenia: a systematic review and meta-analysis of randomized trials. Am J Psychiatry 1999; 156: 990–999.
   PubMed Web of Science ®Google Scholar
• Esposito D, Rouillon F, Limosin F. Continuing clozapine treatment despite neutropenia. Eur J Clin Pharmacol 2005; 60:759–764.
   PubMed Web of Science ®Google Scholar
• Schulte P. What is an adequate trial with clozapine? Therapeutic drug monitoring and time to response in treatment-refractory schizophrenia. Clin Pharmacokinet 2003; 42:607–618.
   PubMed Web of Science ®Google Scholar
• Malalagama G, Bastiampillai T, Dhillon R. Clozapine prescription patterns in Australia over the last 10 years. Aust N Z J Psychiatry 2011; 45:498–499.
   PubMed Web of Science ®Google Scholar
• Carpenter WT Jr, Conley RR, Buchanan RW, Breier A, Tamminga CA. Patient response and resource management: another view of clozapine treatment of schizophrenia. Am J Psychiatry 1995; 152: 827–832.
   PubMed Web of Science ®Google Scholar
• Wheeler A, Humberstone V, Robinson E. Ethnic comparisons of antipsychotic use in schizophrenia. Aust N Z J Psychiatry 2008; 42:863–873.
   PubMed Web of Science ®Google Scholar
• Young CR, Longhurst JG, Bowers MB Jr, Mazure CM. The expanding indications for clozapine. Exp Clin Psychopharmacol 1997; 5:216–234.
   PubMed Web of Science ®Google Scholar
• Serretti A, De Ronchi D, Lorenzi C, Berardi D. New antipsychotics and schizophrenia: a review on efficacy and side effects. Curr Chemistry 2004; 11:343–358.
   PubMed Web of Science ®Google Scholar
• Wetterling T. Bodyweight gain with atypical antipsychotics. A comparative review. Drug Safety 2001; 24:59–73.
   PubMed Web of Science ®Google Scholar